Association of orexin receptor polymorphisms with antipsychotic-induced weight gain (Q47355703)

14 January 2018

title

Association of orexin receptor polymorphisms with antipsychotic-induced weight gain (English)

1 reference

14 January 2018

1 reference

2

Eva J Brandl

1 reference

14 January 2018

Jeffrey Lieberman

7

Jeffrey A Lieberman

1 reference

14 January 2018

Clement C. Zai

3

0 references

Herbert Y. Meltzer

8

0 references

Daniel J. Müller

10

Daniel J Müller

1 reference

14 January 2018

James L. Kennedy

9

James L Kennedy

1 reference

14 January 2018

Nabilah I Chowdhury

5

Nabilah I Chowdhury

1 reference

14 January 2018

author name string

Arun K Tiwari

1

1 reference

14 January 2018

Vanessa F Goncalves

4

1 reference

14 January 2018

Natalie Freeman

6

1 reference

14 January 2018

publication date

8 October 2015

1 reference

14 January 2018

World Journal of Biological Psychiatry

published in

1 reference

14 January 2018

volume

17

1 reference

14 January 2018

issue

3

1 reference

14 January 2018

page(s)

221-229

1 reference

14 January 2018

Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs

cites work

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1076173

Haploview: analysis and visualization of LD and haplotype maps

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1076173

mbmdr: an R package for exploring gene-gene interactions associated with binary or quantitative traits

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1076173

Pretreatment with subeffective doses of Rimonabant attenuates orexigenic actions of orexin A-hypocretin 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1076173

Stigmatisation of people with mental illnesses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1076173

Obesity-driven synaptic remodeling affects endocannabinoid control of orexinergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1076173

Improved whole-chromosome phasing for disease and population genetic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1076173

Pedigree disequilibrium tests for multilocus haplotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1076173

Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1076173

Enhanced orexin receptor-2 signaling prevents diet-induced obesity and improves leptin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1076173

Cannabinoids augment the release of neuropeptide Y in the rat hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1076173

Body weight gain induced by atypical antipsychotics: an extension of the monozygotic twin and sib pair study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1076173

Fast and accurate genotype imputation in genome-wide association studies through pre-phasing

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1076173

Neuronal circuits involving neuropeptide Y in hypothalamic arcuate nucleus-mediated feeding regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1076173

Physiology of the orexinergic/hypocretinergic system: a revisit in 2012

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1076173

A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1076173

Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1076173

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1076173

Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-induced weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1076173

Differential expression of orexin receptors 1 and 2 in the rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1076173

Serotonin subtype 2 receptor genes and clinical response to clozapine in schizophrenia patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1076173

Genetics of antipsychotic treatment emergent weight gain in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1076173

Orexins (hypocretins) directly interact with neuropeptide Y, POMC and glucose-responsive neurons to regulate Ca 2+ signaling in a reciprocal manner to leptin: orexigenic neuronal pathways in the mediobasal hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1076173

Clinical and neurobiological aspects of narcolepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1076173

A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1076173

Role of orexin receptors in obesity: from cellular to behavioral evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1076173

Connectomics of orexin-producing neurons: interface of systems of emotion, energy homeostasis and arousal

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1076173

Increased body-mass index in patients with narcolepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1076173

The role of thermogenesis in antipsychotic drug-induced weight gain.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1076173

Clozapine-induced weight gain: a study in monozygotic twins and same-sex sib pairs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1076173

Association of a functional polymorphism in neuropeptide Y with antipsychotic-induced weight gain in schizophrenia patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1076173

A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-induced weight gain in Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1076173

Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1076173

Clozapine: weight gain in a pair of monozygotic twins concordant for schizophrenia and mild mental retardation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1076173

Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1076173

10.3109/15622975.2015.1076173

21 January 2018

Identifiers

DOI

1 reference

14 January 2018

PubMed ID

26447462

1 reference

14 January 2018